This retrospective, single‐center study included all patients aged 18 to 65 years who presented with ACS and underwent ...
A phase 2 trial evaluating CS-1103 in participants with methamphetamine use disorder is expected to begin in the first quarter of 2026. The Food and Drug Administration (FDA) has granted Fast Track ...
Millions of people use methamphetamine in the United States, and overdoses involving the drug have been rising over the last decade. But while we have a veritable armory of tools to help with other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results